Current
Neuro-Oncology


Volume 24 Number 14
31 July 2022


Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 14, 31 July






Caramanna I, de Kort JM, Brandes AA, Taal W, Platten M, Idbaih A, Frenel JS, Wick W, Preetha CJ, Bendszus M, Vollmuth P, Reijneveld JC, Klein M.
Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101.
Neurooncol Pract. 2022 Mar 13;9(4):310-316
🡥. doi: 10.1093/nop/npac022🡥. PMID: 35855458🡥. Interventional study. 🡥




Uluc K, Ambady P, McIntyre MK, Tabb JP, Kersch CN, Nerison CS, Huddleston A, Liu JJ, Dogan A, Priest RA, Fu R, Prola Netto J, Siler DA, Muldoon LL, Gahramanov S, Neuwelt EA.
Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.
Neurooncol Adv. 2022 Jun 25;4(1):vdac104
🡥. doi: 10.1093/noajnl/vdac104🡥. PMID: 35892048🡥. Observational study. 🡥




Bota DA, Taylor TH, Lomeli N, Kong XT, Fu BD, Schönthal AH, Singer S, Blumenthal DT, Senecal FM, Linardou H, Rokas E, Antoniou DG, Schijns VEJC, Chen TC, Elliot J, Stathopoulos A.
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.
Front Oncol. 2022 Jun 28;12:934638
🡥. doi: 10.3389/fonc.2022.934638🡥. PMID: 35837107🡥. Interventional study. 🡥




Hirano Y, Shinya Y, Aono T, Hasegawa H, Kawashima M, Shin M, Takami H, Takayanagi S, Umekawa M, Ikemura M, Ushiku T, Taoka K, Tanaka S, Saito N.
The Role of Stereotactic Frame-Based Biopsy for Brainstem Tumors in the Era of Molecular-Based Diagnosis and Treatment Decisions.
Curr Oncol. 2022 Jun 28;29(7):4558-4565
🡥. doi: 10.3390/curroncol29070360🡥. PMID: 35877220🡥. Observational study. 🡥




Bjorland LS, Dæhli Kurz K, Fluge Ø, Gilje B, Mahesparan R, Sætran H, Ushakova A, Farbu E.
Butterfly glioblastoma: Clinical characteristics, treatment strategies and outcomes in a population-based cohort.
Neurooncol Adv. 2022 Jul 1;4(1):vdac102
🡥. doi: 10.1093/noajnl/vdac102🡥. PMID: 35892046🡥. Observational study. 🡥




Lavanya G, Uppin MS, Alugolu R, Bhattacharjee S, Saradhi MV, Yeramneni VK.
Clinical Profile, Pathology, and Molecular Typing of Gliomas with Oligodendroglial Morphology: A Single Institutional Experience.
Neurol India. 2022 Jul 1, 2022;70(3):1020-1024
🡥. doi: 10.4103/0028-3886.349641? PMID: 35864633🡥. Observational study. 🡥




Mishra N, Rath GP, Rajagopalan V, Doddamani R, Chaturvedi A.
Perioperative Management of Pediatric Brain Tumors: A Retrospective Analysis.
Neurol India. 2022 Jul 1, 2022;70(3):1095-1101🡥. doi: 10.4103/0028-3886.349578?. PMID: 35864645🡥. Observational study. 🡥




Liu R, Wei W, Hou H, Cong P, Zhou Y, Yu X.
Case Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation.
Onco Targets Ther. 2022 Jul 11;15:771-776
🡥. doi: 10.2147/OTT.S362185🡥. PMID: 35847381🡥. Case report. 🡥




Cole BL, Starr K, Lockwood CM, Leary SES.
The "SEED" Study: The Feasibility of Selecting Patient-Specific Biologically Targeted Therapy with Sorafenib, Everolimus, Erlotinib or Dasatinib for Pediatric and Young Adult Patients with Recurrent or Refractory Brain Tumors.
Front Biosci (Landmark Ed). 2022 Jul 12;27(7):219
🡥. doi: 10.31083/j.fbl2707219🡥. PMID: 35866410🡥. Interventional study. 🡥



*

Chen N, Alieva M, van der Most T, Klazen JAZ, Vollmann-Zwerenz A, Hau P, Vrisekoop N.
Neutrophils Promote Glioblastoma Tumor Cell Migration after Biopsy.
Cells. 2022 Jul 14;11(14):2196
🡥. doi: 10.3390/cells11142196🡥. PMID: 35883641🡥. Laboratory investigation. 🡥




Lassman AB, Pugh SL, Wang TJC, Aldape K, Gan HK, Preusser M, Vogelbaum MA, Sulman EP, Won M, Zhang P, Moazami G, Macsai MS, Gilbert MR, Bain EE, Blot V, Ansell PJ, Samanta S, Kundu MG, Armstrong TS, Wefel JS, Seidel C, de Vos FY, Hsu S, Cardona AF, Lombardi G, Bentsion D, Peterson RA, Gedye C, Bourg V, Wick A, Curran WJ, Mehta MP.
Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial.
Neuro Oncol. 2022 Jul 15:noac173
🡥. doi: 10.1093/neuonc/noac173🡥. PMID: 35849035🡥. Interventional study. 🡥




Melnick KF, Miller P, Carmichael E, McGrath K, Ghiaseddin A, Tran DD, Rahman M.
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival.
J Neurooncol. 2022 Jul 15🡥. doi: 10.1007/s11060-022-04083-8🡥. PMID: 35840786🡥. Observational study; 🡥




Hagiwara A, Schlossman J, Shabani S, Raymond C, Tatekawa H, Abrey LE, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Cloughesy TF, Ellingson BM.
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.
J Neurooncol. 2022 Jul 17
🡥. doi: 10.1007/s11060-022-04088-3🡥. PMID: 35842871🡥. Interventional study. 🡥




Thakur S, Kumar N, Salunke P, Ahuja C, Madan R.
A Randomized Study of Short Course (One Week) Radiation Therapy with or without Temozolomide in Elderly and/or Frail Patients with Newly Diagnosed Glioblastoma (GBM).
Asian Pac J Cancer Prev. 2022 Jul 17;23(7):2317-2323
🡥. doi: 10.31557/APJCP.2022.23.7.2317🡥. PMID: 35901337🡥. Interventional study. 🡥




Kline C, Jain P, Kilburn L, Bonner ER, Gupta N, Crawford JR, Banerjee A, Packer RJ, Villanueva-Meyer J, Luks T, Zhang Y, Kambhampati M, Zhang J, Yadavilli S, Zhang B, Gaonkar KS, Rokita JL, Kraya A, Kuhn J, Liang W, Byron S, Berens M, Molinaro A, Prados M, Resnick A, Waszak SM, Nazarian J, Mueller S.
Upfront biology-guided therapy in diffuse intrinsic pontine glioma: therapeutic, molecular, and biomarker outcomes from PNOC003.
Clin Cancer Res. 2022 Jul 19:CCR-22-0803
🡥. doi: 10.1158/1078-0432.CCR-22-0803🡥. PMID: 35852795🡥. Interventional study. 🡥




Yogendran LV, Kalelioglu T, Donahue JH, Ahmad H, Phillips KA, Calautti NM, Lopes MB, Asthagiri AR, Purow B, Schiff D, Patel SH, Fadul CE.
The landscape of brain tumor mimics in neuro-oncology practice.
J Neurooncol. 2022 Jul 20🡥. doi: 10.1007/s11060-022-04087-4🡥. PMID: 35857249🡥. Observational study; 🡥




Voisin MR, Zuccato JA, Wang JZ, Zadeh G.
Surgery for recurrent GBM: a retrospective case-control study.
World Neurosurg. 2022 Jul 21:S1878-8750(22)01019-1🡥. doi: 10.1016/j.wneu.2022.07.070🡥. PMID: 35870781🡥. Observational study;
🡥




Luger AL, König S, Samp PF, Urban H, Divé I, Burger MC, Voss M, Franz K, Fokas E, Filipski K, Demes MC, Stenzinger A, Sahm F, Reuss DE, Harter PN, Wagner S, Hattingen E, Wichert J, Lapa C, Fröhling S, Steinbach JP, Ronellenfitsch MW.
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.
J Neurooncol. 2022 Jul 21🡥. doi: 10.1007/s11060-022-04049-w🡥. PMID: 35864412🡥. Observational study.
🡥




Ohno M, Miyakita Y, Takahashi M, Yanagisawa S, Tamura Y, Narita Y.
Continuing maintenance temozolomide therapy beyond 12 cycles confers no clinical benefit over discontinuation at 12 cycles in patients with IDH1/2-wildtype glioblastoma.
Jpn J Clin Oncol. 2022 Jul 21:hyac114🡥. doi: 10.1093/jjco/hyac114🡥. PMID: 35858227🡥. Observational study;
🡥




Todo T, Ino Y, Ohtsu H, Shibahara J, Tanaka M.
A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma.
Nat Commun. 2022 Jul 21;13(1):4119🡥. doi: 10.1038/s41467-022-31262-y🡥. PMID: 35864115🡥. Interventional study. 🡥



*

Todo T, Ito H, Ino Y, Ohtsu H, Ota Y, Shibahara J, Tanaka M.
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.
Nat Med. 2022 Jul 21🡥. doi: 10.1038/s41591-022-01897-x🡥. PMID: 35864254🡥. Interventional study. 🡥




Kamble AN, Agrawal NK, Koundal S, Bhargava S, Kamble AN, Joyner DA, Kalelioglu T, Patel SH, Jain R.
Imaging-based stratification of adult gliomas prognosticates survival and correlates with the 2021 WHO classification.
Neuroradiology. 2022 Jul 25
🡥. doi: 10.1007/s00234-022-03015-7🡥. PMID: 35876874🡥. Observational study; 🡥




Pant I, Chaturvedi S, S Gautam VK, Sarma P, Satti DK.
Extra-axial adult cerebellopontine angle medulloblastoma: Revisiting a rare entity.
J Cancer Res Ther. 2022 Jul 25, 2022;18(3):770-773
🡥. doi: 10.4103/jcrt.JCRT_675_20🡥. PMID: 35900553🡥. Case report. 🡥




Steininger K, Kahl KH, Konietzko I, Wolfert C, Motov S, Krauß PE, Bröcheler T, Hadrawa M, Sommer B, Stüben G, Shiban E.
Intraoperative radiotherapy during awake craniotomies: preliminary results of a single-center case series.
Neurosurg Rev. 2022 Jul 26
🡥. doi: 10.1007/s10143-022-01838-9🡥. PMID: 35881316🡥. Observational study. 🡥




Schepke E, Löfgren M, Pietsch T, Bontell TO, Kling T, Wenger A, Vega SF, Danielsson A, Dosa S, Holm S, Öberg A, Nyman P, Eliasson-Hofvander M, Sandström PE, Pfister SM, Lannering B, Sabel M, Carén H.
DNA methylation profiling improves routine diagnosis of paediatric CNS tumours: a prospective population-based study.
Neuropathol Appl Neurobiol. 2022 Jul 26:e12838
🡥. doi: 10.1111/nan.12838🡥. PMID: 35892159🡥. Observational study; 🡥




Gao S, Jin L, Moliterno J, Corbin ZA, Bindra RS, Contessa JN, Yu JB, Park HS.
Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma.
J Neurosurg. 2022 Jul 29:1-11🡥. doi: 10.3171/2022.5.JNS212761? PMID: 35907197🡥. Observational study;
🡥




Guan Y, Pan M, Yang J, Lu Q, Han L, Liu Y, Li J, Zhu H, Gong X, Mei G, Liu X, Pan L, Dai J, Wang Y, Wang E, Wang X.
A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol.
BMC Cancer. 2022 Jul 29;22(1):827🡥. doi: 10.1186/s12885-022-09914-5🡥. PMID: 35906549🡥. Interventional study.
🡥




Stoltze UK, Foss-Skiftesvik J, van Overeem Hansen T, Byrjalsen A, Sehested A, Scheie D, Mikkelsen TS, Rasmussen S, Bak M, Okkels H, Callesen MT, Skjøth-Rasmussen J, Gerdes AM, Schmiegelow K, Mathiasen R, Wadt K.
Genetic predisposition & evolutionary traces of pediatric cancer risk: A prospective 5-year population-based genome sequencing study of children with CNS tumors.
Neuro Oncol. 2022 Jul 29:noac187
🡥. doi: 10.1093/neuonc/noac187🡥. PMID: 35902210🡥. Interventional study; 🡥